Question 1

What is the share price of Corona Remedies Ltd today?

Accepted Answer

Corona Remedies Ltd (CORONA) is trading at ₹2,051.1. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is CORONA’s P/E ratio versus the sector?

Accepted Answer

CORONA trades at a P/E of 58.2. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is CORONA’s dividend yield?

Accepted Answer

CORONA has a dividend yield of 0.50%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is CORONA’s 52-week high and low?

Accepted Answer

CORONA has traded between ₹1,336.6 and ₹2,292.4 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Corona Remedies Ltd?

Accepted Answer

Corona Remedies Ltd has a market capitalisation of ₹12,326 crore.

Question 6

What is CORONA’s return on equity?

Accepted Answer

CORONA reports a return on equity of 29.5%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - General.

Question 7

Who are CORONA’s competitors?

Accepted Answer

The Peers block on this page lists other Drug Manufacturers - General companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is CORONA’s promoter holding?

Accepted Answer

Promoters hold 69.00% of CORONA. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include CORONA?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight CORONA carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Corona Remedies Ltd a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from CORONA’s own numbers. The judgement is yours.

Revenue	₹1,403 crore
Net profit	₹185 crore
Operating margin	21%
EPS	₹30.22

CORONA

CORONA

Fundamental Strength Index

Profitability

Growth

Segment Results

Working Capital & Efficiency

CORONA financial summary